VIPERGEN R & D III K/S: Financial statements 2017
CVR: 30355644
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
VIPERGEN R & D III K/S (CVR 30355644) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 156,000 and a net result of DKK 211,000 compared with DKK -52,000 the year before. Equity in the 2017 report amounted to DKK 159,000. The solvency ratio was 6.9%.
- Gross Profit
- DKK 156,000
- Profit/Loss
- DKK 211,000
- Equity
- DKK 159,000
- Total Assets
- DKK 2,298,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 156K | 211K | 159K | - |
| 2016 | - | - | -52K | -52K | - |
| 2015 | 0 | - | -932K | 0 | - |
| 2014 | 805K | - | -12.3M | 932K | - |
| 2013 | 804K | - | -10.7M | -1.8M | - |
Official annual report
Keep an eye on VIPERGEN R & D III K/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
VIPERGEN R & D III K/S has published its annual report for 2016. The net result was DKK -52,000.
About VIPERGEN R & D III K/S
VIPERGEN R & D III K/S was a Danish company of the type Kommanditselskab based in København V, founded in 2007. The company has been dissolved on 31 May 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2018, the company reported a gross profit of DKK -10,000 and a net result of DKK -7,000 compared with DKK 211,000 the year before. Equity in the 2018 report amounted to DKK 152,000.